Introduction
============

Head injuries are associated with a high level of morbidity and mortality. The aim of this study was to examine if S~100~, a calcium binding protein localised in astroglial cells of the central nervous system, can be used as a marker of head injury and to predict survival outcomes from severe head injury.

Methods
=======

After informed consent and local ethics approval, 12 severe head injured patients (GCS ≤ 8) were included. All patients were treated according to standardised head injury protocols. Serial serum samples were taken over a period of 48 h together with various other physiologic measurements. Plasma concentrations of S~100~ were analysed using a radioimmunometric assay - Sangtec^®^ S~100~ IMRA.

Results
=======

The mean S~100~ in patients who survived was 1.1 μg/l and in those who died 0.79 μg/l. Six of the 12 patients in the study died.

Conclusion
==========

Plasma S~100~ concentrations increase in severe head injuries. The reference value is less than 0.2 μg/l and this was exceeded in both patients who survived and those who died. Serum S~100~ levels could not be correlated with mortality.

###### 

Serum S~100~ (μ g/l) after severe head injury

  Time after admission (h)   0                 2       6      12     24     48     72     
  -------------------------- ----------------- ------- ------ ------ ------ ------ ------ ------
  S~100~ (μ g/l)             Mean              0.417   0.5    1.25   1.06   2.49   0.7    0.35
                             Std deviation     0.59    0.74   2.68   1.72   6.54   1.16   0.64
                             No. of patients   12      12     12     12     12     12     6
